3TR – Taxonomy, Treatment, Targets and Remission
3TR aims to provide fundamental new insights into the mechanisms of response and non-response to treatment. Therefore, they challenge the conventional “single disease”-based approach, in which diseases are classified according to their end-organ involvement rather than the molecular pathways underpinning them. They propose a paradigm shift in the way we look at diseases: Promoting a scientific evidence-based rationale for treatment selection, rather than following the traditional trial and error approach, 3TR will have significant implications for future patient management and the assessment of efficacy, safety and quality of future health products.
- Researcher: Jose Antonio Garcia Salcedo
- Group: E16-EMERGING AND TRANSLATIONAL MICROBIOLOGY
- Centre: Institute of Biosanitary Research ibs.GRANADA / University Hospital Virgen de las Nieves
- Role in the project: Partners
- Duration: 2019 – 2026
Project website: https://3tr-imi.eu/